BIFIDO
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
150 Jojeong-daero, Gyeonggi-do, Gyeonggi...Phone Number
+82 3180278941Website
www.bifido.comRevenue
<$5 MillionIndustry
About BIFIDO
BIFIDO Org Chart
Is BIFIDO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
BIFIDO, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if BIFIDO is spiking on competitors!
Earning: See what the market has to say on BIFIDO recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if BIFIDO has recently received funding, and reach out quickly before it becomes old news!
Click to see if BIFIDO had a recent Job posting/layoffs
Product Launch: Get notified when BIFIDO launches new products
Congratulate Masked Content for being promoted to Masked Content at BIFIDO
Funding: Get notified immidiatlly once BIFIDO has new funding data
Recommended Actions
Find VP level buyers at BIFIDO
Find more new buyers
Company Profile Activity
Activity Insights
BIFIDO is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BIFIDO is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BIFIDO.
BIFIDO Tech Stack
A closer look at the technologies used by BIFIDO
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BIFIDO
Bifido specializes in microbiome healthcare, focusing on the development of probiotics and pharmabiotics derived from human sources. Their integrated platform offers a one-stop solution for product development, from research to manufacturing, utilizing advanced immunomodulatory technology and engineered Bifidobacterium strains. The company targets... Read More